Edition:
United States

Gerresheimer AG (GXIG.DE)

GXIG.DE on Xetra

72.95EUR
17 Aug 2018
Change (% chg)

€-0.65 (-0.88%)
Prev Close
€73.60
Open
€73.85
Day's High
€74.00
Day's Low
€72.50
Volume
62,079
Avg. Vol
100,397
52-wk High
€78.90
52-wk Low
€59.61

Chart for

About

Gerresheimer AG is a Germany-based company that is active in the pharmaceuticals and health care industry. It operates through two business segments: Plastics and Devices, and Primary Packaging Glass. The Plastics and Devices segment produces standard and customized products for drug delivery, such as insulin pens, inhalers, and... (more)

Overall

Beta: 0.57
Market Cap(Mil.): €2,290.63
Shares Outstanding(Mil.): 31.40
Dividend: 1.10
Yield (%): 1.51

Financials

  GXIG.DE Industry Sector
P/E (TTM): 26.28 37.48 30.17
EPS (TTM): 2.78 -- --
ROI: 5.56 14.29 12.67
ROE: 11.47 17.46 14.86

Deals of the day-Mergers and acquisitions

July 12 The following bids, mergers, acquisitions and disposals were reported by 2030 GMT on Thursday:

Jul 12 2018

Deals of the day-Mergers and acquisitions

July 12 The following bids, mergers, acquisitions and disposals were reported by 1000 GMT on Thursday:

Jul 12 2018

Gerresheimer buys Swiss firm Sensile Medical for up to 350 mln euros

* Maximum price of 350 mln euros depends on meeting milestones

Jul 12 2018

German stocks - Factors to watch on July 12

BERLIN, July 12 The following are some of the factors that may move German stocks on Thursday:

Jul 12 2018

German stocks - Factors to watch on April 25

FRANKFURT, April 25 The following are some of the factors that may move German stocks on Wednesday:

Apr 25 2018

European shares rise as Syria standoff worries recede

MILAN/LONDON European shares rose on Thursday alongside a relief rally across global markets after U.S. President Trump signaled that military strikes in Syria may not be imminent.

Apr 12 2018

UPDATE 2-European shares rise as Syria standoff worries recede

* Sulzer freed of U.S. sanctions, shares rally (Adds closing prices)

Apr 12 2018

BRIEF-Gerresheimer Posts Rise in Q4 Profit, Hikes Dividend​

* FOURTH-QUARTER REVENUES UP 4.7%, WITH ORGANIC GROWTH OF 6.7%.‍​

Feb 22 2018

Earnings vs. Estimates